GLP-1s like Ozempic, Mounjaro may cut fracture risk in type 2 diabetes
New evidence suggests that medications in the GLP-1 family, including semaglutide (branded as Ozempic) and the dual GIP/GLP-1 agent tirzepatide (Mounjaro), may do more than lower blood sugar and body weight. Researchers now point to a possible link between these drugs and a reduced risk of bone fractures in people …
Dishes
Desserts
Travels
Subscribe to the Newsletter
Ready to nourish your body and soul? Join the Knead to Cook community and get inspired to live your healthiest, most vibrant life — one plant-based recipe at a time.
Health
Lifestyle
Must Read
News
Martha Stewart turns 85: see her life in photos
Martha Stewart transformed the ordinary rituals of home life into a global business and cultural phenomenon. She started by sharing recipes and decorating tips and …
